Where Will Novo Nordisk Stock Be in 5 Years?
The Motley Fool
SEPTEMBER 22, 2023
Novo Nordisk (NYSE: NVO) has been growing in popularity as a result of two incredibly popular drugs, Ozempic and Wegovy. Because of the company's phenomenal growth, it has been a top buy for many investors. But the business is still growing and Novo Nordisk's top and bottom lines should continue rising in the future. Here's where I see the company being five years from now.
Let's personalize your content